Lv6
1630 积分 2020-10-26 加入
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
2天前
已完结
Real-world trends in diagnosis, treatment, and survival of non–small cell lung cancer in Vietnam
2天前
已关闭
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
10天前
已完结
Denatured collagen inhibits neuroblastoma tumor-sphere migration and growth via the LOX/LOXL2 – FAK signaling pathway
1个月前
已完结
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis
2个月前
已完结
Financial evaluation of value-creating biosimilar development candidates: a business case study of low-, medium- and high-sales biosimilars
3个月前
已完结
Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050
3个月前
已完结
A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjects
5个月前
已完结
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux®) in Healthy Chinese Male Subjects
5个月前
已完结
Spatiotemporal trends in the burden of colorectal cancer incidence and risk factors at country level from 1990 to 2019
8个月前
已完结
皖公网安备34019202002308
